Pharmacological Primary and Secondary Cardiovascular Prevention Among Diabetic Patients in a Multiethnic General Practice Population: Still Room for Improvements

BMC Health Services Research - United Kingdom
doi 10.1186/1472-6963-13-182
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Omega-6 Fats for the Primary and Secondary Prevention of Cardiovascular Disease

Cochrane Database of Systematic Reviews
2018English

PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease

2015English

Secondary Pharmacotherapeutic Prevention Among German Primary Care Patients With Peripheral Arterial Disease

International Journal of Vascular Medicine
Cardiovascular MedicineCardiology
2011English

Omega-3 Fatty Acids for the Primary and Secondary Prevention of Cardiovascular Disease

Cochrane Database of Systematic Reviews
2020English

Cardiovascular Risk Factors Among Malaysian Diabetic Patients

International Archives of Medicine
2016English

Should All Diabetic Patients Be on Aspirin for Primary Prevention?

Expert Review of Cardiovascular Therapy
Internal MedicineMedicineCardiovascular MedicineCardiology
2019English

Non-Participation in Population-Based Disease Prevention Programs in General Practice

BMC Public Health
EnvironmentalPublic HealthOccupational Health
2012English

Primary Prevention of Cardiovascular Events With Low-Dose Aspirin and Vitamin E in Type 2 Diabetic Patients: Results of the Primary Prevention Project (PPP) Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2003English

Cardiovascular Risk Prediction for Primary Prevention

Prescriber
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy